MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Increased and symmetric expression of rigidity in early Parkinson’s disease with abnormal REM sleep without atonia

    M. Petrucci, S. Amundsen Huffmaster, C. Lu, P. Tuite, M. Howell, C. MacKinnon (Minneapolis, MN, USA)

    Objective: The purpose of this study was to compare the level and bilateral expression of upper arm rigidity between people with early stage Parkinson’s disease…
  • 2017 International Congress

    Evaluation of spike sorting algorithms applied to artificial spikes and to spikes recorded from the Subthalamic Nucleus of PD patients

    J. Sukiban, N. Voges, I. Weber, T. Dembek, M. Denker, M. Barbe, S. Grün, L. Timmermann (Cologne, Germany)

    Objective: To evaluate the variability in spike sorting results using different clustering algorithms  Background: Extracellular currents recorded from the Subthalamic Nucleus (STN) of PD patients,…
  • 2017 International Congress

    Freezing of gait in Parkinson’s disease consists of unique pressure-based gait phase transitions

    L. Luo, D. Zanotto, F. Maget, B. Xu, S. Agrawal, P. Mazzoni (New York, NY, USA)

    Objective: To develop a method to detect freezing of gait in real time Background: Freezing of gait (FOG) is a major debilitating symptom and cause…
  • 2017 International Congress

    Clinical feasibility of a wearable, conformable, sensor patch to monitor motor symptoms in Parkinson’s disease

    B. Boroojerdi, K. Claes, R. Ghaffari, N. Mahadevan, M. Markowitz, K. Melton, B. Morey, C. Otoul, S. Patel, J. Phillips, E. Sen-Gupta, O. Stumpp, D. Tatla, J. Wright Jr, N. Sheth (Monheim am Rhein, Germany)

    Objective: 2-part pilot study to evaluate feasibility of a wearable sensor, the prototype NIMBLE system sensor patch, to assess motor symptoms in Parkinson’s disease (PD) patients.…
  • 2017 International Congress

    Evaluation of the short-term and long-term effects of an intensive multidisciplinary collective rehabilitation program over 5 weeks in Parkinson’s patients followed in Lyon

    T. DANAILA, C. LAURENCIN, P. ROCHE, S. THOBOIS, M. CHEMINON, J. LUAUTE (BRON, France)

    Objective: We studied the value of collective (8 patients per group) intensive multidisciplinary collective rehabilitation in the short and long term. Background: Numerous studies have proved…
  • 2017 International Congress

    Neuropsychological profile of corticobasal degeneration, progressive supranuclear palsy and frontotemporal dementia patients

    M.M. Carmona-Abellan, M. Riverol, M. Recio, B. Echeveste, L. Imaz, R. Luquin (Pamplona, Spain)

    Objective: To study and compare the neuropsychological profile of patients with corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), non-fluent progressive aphasia (NFPA) and frontotemporal behavioral…
  • 2017 International Congress

    MANF protects dopamine neurons and locomotion defect from Neurotoxin/Human alpha-synuclein-induced progressive Parkinson’s disease models in C.elegans.

    Z. Zhang (Shanghai, China)

    Objective: To study whether Mesencephalic astrocyte-derived neurotrophic factor (MANF) has beneficial effects in parkinson disease and its intracellular mechanisms.  Background: The distinguishing feature of Parkinson’s…
  • 2017 International Congress

    Prediction of cognitive progression in Parkinson’s disease using three cognitive screening measures

    C. Nazor, C. Zabetian, C. Johnson, B. Fish, J. Quinn, K. Chung, A. Peterson-Hiller, S.-C. Hu, T. Montine, J. Leverenz, K. Edwards, B. Cholerton (Seattle, WA, USA)

    Objective: To assess the utility of commonly used cognitive screening tools in predicting the transition to mild cognitive impairment (MCI) and/or dementia (PDD) in Parkinson’s…
  • 2017 International Congress

    Spiral Analysis is a Promising Biomarker in LRRK2 G2019S carriers

    R. Ortega, M. Pullman, A. Glickman, I. Perera, M. San Luciano, A. Mirelman, C. Pont-Sunyer, N. Giladi, E. Tolosa, Q. Yu, S. Bressman, S. Pullman, R. Saunders-Pullman (New York, NY, USA)

    Objective: To assess whether harboring a LRRK2 G2019S mutation is associated with abnormalities in spiral drawing, including in mutation carriers with Parkinson Disease (PD) as…
  • 2017 International Congress

    Expression of OX40 and OX40 serum level in patients with Parkinson’s disease

    F. Alsahebfosoul, A. SeyedJoodaki, N. Eskandari, V. Shaygannejad, M. Salehi, M. Kazemi, M.T. Kardi, O. Mirmossayeb (Isfahan, Islamic Republic of Iran)

    Objective: Study the expression of OX40 gene and its serum levels  could be measured to predict and confirm diagnosis of Parkinson's disease and help develop new…
  • « Previous Page
  • 1
  • …
  • 294
  • 295
  • 296
  • 297
  • 298
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley